ID   iPS87
AC   CVCL_YZ64
DR   Wikidata; Q98126787
RX   PubMed=32256979;
CC   Characteristics: Highly tumorigenic. Established from prostate cancer stem cells.
CC   Doubling time: ~42 hours (PubMed=32256979).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
RX   PubMed=32256979; DOI=10.18632/oncotarget.27524; PMCID=PMC7105161;
RA   Assoun, Erika N.
RA   Meyer, April N.
RA   Jiang, Maggie Y.
RA   Baird, Stephen M.
RA   Haas, Martin
RA   Donoghue, Daniel J.
RT   "Characterization of iPS87, a prostate cancer stem cell-like cell
RT   line.";
RL   Oncotarget 11:1075-1084(2020).
//